In contrast, CTLA-4-Ig (abatacept) suppressed experimental autoimmune uveitis by expanding Tregs (CD4+CD25+Foxp3+ cells increased by 2.7-fold) and reducing Th17 cytokines (IL-17A ↓89%).40 The gene discussed is CTLA4; the disease is autoimmune uveitis.